Evidence map›Paper›PMID 41352870›Full record

ReviewProgress in nuclear magnetic resonance spectroscopy

NMR-based metabolomics: Where are we now and where are we going?

G A Nagana Gowda, Wentao Zhu, Daniel Raftery

Abstract readReview
In one paragraph

Review in Progress in nuclear magnetic resonance spectroscopy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Metabolites · 2026
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

G A Nagana GowdaNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA; Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA.
Wentao ZhuNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA; Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA.
Daniel RafteryNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA; Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington 98109, USA; Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA. Electronic address: draftery@uw.edu.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON · 1986 to 2026
$30.4M
Nutrition and Physical Activity Assessment Study (NPAAS)R01CA119171 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian L Neuhouser · 2006 to 2026
$14.3M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI Jennifer Michelle Davis, DANIEL RAFTERY · 2019 to 2026
$7.5M
Modeling Homeostasis of Human Blood MetabolitesR01GM131491 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL, ZHANG, DABAO · 2020 to 2023
$2.2M
Quantitative Analysis of Labile Metabolites in Biological SamplesR01GM138465 · NIGMS · UNIVERSITY OF WASHINGTON · PI GOWDA, G. A. NAGANA, RAFTERY, DANIEL · 2021 to 2024
$1.5M
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA119171NIAMS NIH HHS P30 AR074990NIDDK NIH HHS P30 DK035816NIGMS NIH HHS R01 GM131491NIGMS NIH HHS R01 GM138465
6 · The paper itself

Abstract

The fast-growing field of metabolomics focuses on the analyses of complicated mixtures of small molecules present in biological samples. To date, metabolomics has provided a wealth of information on biological systems and impacted numerous areas of basic and life sciences. A major focus of metabolomics has been on biomedicine with the goal of biomarker discovery, drug discovery and improved mechanistic understanding of the pathogenesis of many human diseases. Analytical methods play a pivotal role in metabolomics, with the two most widely used platforms being nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Among their many complementary capabilities, NMR is generally more reproducible and quantitative, whereas MS is more sensitive. Recent technological advances in NMR have resulted in multifaceted developments, including improvements in sensitivity, resolution and speed, along with expanded metabolite identification and quantitation, which together provide exciting potential for future studies. In addition to NMR developments, the combination of NMR with MS provides numerous benefits that are becoming more evident over time. Hence, the metabolomics field has witnessed an increased number of studies and applications that combine NMR with MS in numerous areas, including new methods development for unknown identification, metabolite quantitation, disease biomarker discovery, mechanistic understanding of disease pathogenesis, and dietary risk factors of diseases among others. This report describes the current status of state-of-the-art methods in NMR-based metabolomics, along with recent advances and future prospects, with an emphasis on the benefits of combining NMR with MS.

Indexed as

MetabolomicsAnimalsBiomarkersHumansMagnetic Resonance SpectroscopyMass SpectrometryBiomarkersBiomarker discoveryHealthMass spectrometryNMR spectroscopyNutritionQuantitationUnknown identification

Identifiers

PMID41352870
PMCPMC12681757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.